Representatives Of The NPC And CPPCC Members Talked About Chinese Medicine: It Is Recommended To Be Included In The National Infectious Disease Prevention And Control System To Encourage The Development Of Innovative Drugs.

Chinese medicine has played a major role in the fight against the outbreak of new crown pneumonia. The clinical effectiveness of Chinese medicine has been confirmed. On the occasion of the coming two sessions of the national conference, several representatives of the NPC and CPPCC National Committees put forward relevant suggestions on how to better serve the public health service and how to promote the development of the industry.

Academician Zhang Boli, deputy to the National People's Congress, said that if we could integrate traditional Chinese medicine into the infectious disease prevention system and the whole system of major diseases, the development of Chinese medicine would be more proactive. It is suggested that the relevant contents of Chinese medicine be included in the infectious disease prevention act.

Xu Jingren, chairman of the National People's Congress and chairman of Yangtze River Pharmaceutical Group, said that the unique role of Chinese medicine has been verified in the actual combat of the epidemic, but the development of Chinese medicine still faces challenges of insufficient inheritance and insufficient innovation. We hope that the state will encourage clinical evidence based research after listing.

National infectious disease prevention and control system

Data showed that 74187 of the national confirmed cases of new crown pneumonia were used in Chinese medicine, accounting for 91.5%, of which 61449 in Hubei Province used Chinese medicine, accounting for 90.6%. The clinical efficacy showed that the total effective rate of TCM was over 90%.

Academician Zhang Boli also pointed out that in the new crown pneumonia epidemic situation, the clinical validity of Chinese medicine was confirmed.

In order to better play the role of Chinese medicine, Zhang Boli suggested that the relevant contents of Chinese medicine be included in the "Infectious Disease Prevention Act". From the perspective of the long-term development of Chinese medicine, we should increase the training of talents in infectious diseases, severe treatment and other fields, especially the medical staff should be encouraged to exercise at the grass-roots level, and regularly rotate to improve clinical diagnosis and treatment skills.

Lu Chuanjian, vice chairman of the Chinese people's Political Consultative Conference and vice president of Guangdong Province Traditional Chinese Medical Hospital, also expressed similar views. Lu Chuanjian said that Chinese medicine has unique advantages in preventing and treating infectious diseases. In the long run, it is suggested that traditional Chinese medicine should be included in the national infectious disease prevention and control system, so that Chinese medicine can play a greater role in this infectious disease.

Lu Chuanjian pointed out that the current Chinese medicine routine has not been included in the national infectious disease prevention and control system, and the state has not established a Chinese medicine epidemic prevention research system. None of the infectious diseases hospitals in the whole country is a Chinese medicine hospital that can treat infectious diseases and a Chinese medicine research institution that studies infectious diseases. Work.

"It is suggested that at the national level, it is a systematic process to integrate traditional Chinese medicine into the whole national infectious disease system and allow traditional Chinese medicine practitioners to participate in the whole process of management, including flow adjustment, monitoring, decision-making, planning, prevention and research." Lu Chuanjian said.

Lu Chuanjian suggested that the state should introduce the guiding principles, including the establishment of the Chinese medicine management department and the Chinese medicine research office at the national, provincial and municipal centers for Disease Control and prevention. In the whole country, we should select and focus on the construction of clinical designated medical institutions for the prevention and treatment of infectious diseases by Chinese medicine. The State shall give priority to support; establish a research system for infectious diseases in Chinese medicine; at the same time, optimize the work plan for the prevention and treatment of infectious diseases by traditional Chinese medicine. Establish a strong leadership decision-making mechanism and expert consultation mechanism.

Zhang Zhilong, deputy head of the National People's Congress and Tianjin new crown pneumonia expert group of Chinese medicine prevention and treatment, believes that the lack of Chinese medicine system in the current disease prevention system has affected the early intervention and deep integration of Chinese medicine. Zhang Zhilong suggested that we should give full play to the role of Chinese medicine in disease prevention and public health emergencies, and introduce standardized training of Chinese medicine residents. Round robin plan; adjust Chinese medicine charging items, promote the inheritance and innovation development of traditional Chinese medicine.

Zhang Zhilong also called for the revision of the "emergency public health emergency Ordinance" as soon as possible, and to increase the relevant provisions of the role of Chinese medicine in order to better implement the "Chinese medicine law" and unimpede the channels for Chinese medicine to participate in disease prevention and public health emergencies, and provide system guarantee for the prevention and emergency disposal of Chinese medicine.

R & D and intelligent manufacturing

At present, the development of traditional Chinese medicine is still facing the severe challenge of insufficient inheritance and insufficient innovation.

Xu Jingren, chairman of the National People's Congress and chairman of Yangtze River Pharmaceutical Group, said that the inheritance and innovation of traditional Chinese medicine should be guided by clinical needs, and maintain the characteristics of traditional Chinese medicine and the system of Chinese medicine.

In twenty-first Century, the economic report reporters combed Xu Jing's suggestion that he will focus on the innovation and development of Chinese medicine and how to support TCM informatization this year.

Xu Jing recommends that the state support and promote the development of innovative Chinese medicine, as well as the development of Chinese medicine preparations with the advantage of clinical value, safety and effectiveness, encourage the development of clinical evidence-based medicine after the listing of Chinese medicine, and vigorously protect the traditional products and processes of traditional Chinese medicine.

He also proposed that we should guide and support the construction of Chinese medicine information and intelligent manufacturing system, and carry out intelligent upgrading from the aspects of planting, harvesting, processing, preparation, quality inspection, storage and transportation, so as to enhance the overall quality control level of Chinese medicine and promote the upgrading of Chinese medicine industry to green manufacturing and intelligent manufacturing.

The key to the development of traditional Chinese medicine is genuine medicinal materials. How to carry out standardized planting of genuine medicinal materials and promote sustainable and healthy development of Chinese medicinal resources? Xu Jing suggested that we should carry out production and localization, improve seed production, planting ecology, mechanization of production, large-scale development, industrial informatization and product branding, and promote the healthy and sustainable development of Chinese herbal medicine production.

At present, the overall scale of the Chinese medicine industry has exceeded 800 billion yuan, of which the scale of Chinese herbal medicine has exceeded 200 billion yuan, and the scale of the Chinese medicine dispensing granules has also been close to 20 billion yuan. However, there are still some problems in the traditional Chinese medicine dispensing industry. For example, the production enterprises can not establish the base for planting raw materials, which can control the raw materials. The quality of the raw materials is not easy to control, and the price of raw materials is rising or falling.

For this reason, Lu Qingguo, chairman of the National People's Congress and chairman of Chenguang biotechnology group, also put forward relevant suggestions. For example, it is recommended that the State Drug Administration should encourage the production and circulation of all kinds of formula granules on the basis of open standards and unified standards, and introduce policies to encourage every production enterprise to do several kinds of Chinese medicine granule products according to their own strength. From the construction of raw material base, to the production process research, management promotion and product sales, bigger and stronger, and at the same time, the policy of encouraging Chinese medicine to support granule enterprises is introduced to make classification of pharmaceutical residues and make comprehensive use research, and encourage them to be used in medicine, food, feed and other industries.

?